Today: 19 June 2026
Browse Category

Earnings Reports 8 January 2026 - 9 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

GSK shares slipped 0.6% to 1,879.5p in London by 10:50 GMT as investors awaited detailed data from its phase III hepatitis B drug trial. Analysts pressed for cure rate and durability figures after GSK withheld specifics. A royalty dispute over cancer drug Jemperli is pending in U.S. court, with a trial set for July 2026. Investors are watching for updates at the Jan. 13 J.P. Morgan conference and Feb. 4 results.
9 January 2026
···
UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

U.S. House committees summoned UnitedHealth and four other insurers to testify on coverage affordability Jan. 22. UnitedHealth shares rose 1.5% to $346.85 after Wolfe Research raised its price target to $400. The company reports 2025 earnings and 2026 guidance Jan. 27. Senators also accused UnitedHealth of withholding documents in a nursing home care probe.
9 January 2026
·····
Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

Thermo Fisher shares fell 1.7% to $606.50 Thursday, extending losses after reaching a 52-week high of $628.08 earlier in the week. Trading volume topped 3 million shares, nearly double the average. The company will present at the J.P. Morgan Healthcare Conference on Jan. 13 and report earnings Jan. 29. Investors await updates on the $8.9 billion Clario acquisition, expected to close by mid-2026.
9 January 2026
··
AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls

AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls

AbbVie shares fell 4% to $224.13 in after-hours trading Thursday after the company cut its 2025 adjusted profit forecast and disclosed a $1.3 billion acquired R&D charge. The company lowered its full-year 2025 adjusted EPS outlook to $9.90–$9.94 from $10.61–$10.65. AbbVie denied takeover talks with Revolution Medicines. Investors await the company’s Feb. 4 earnings report for further guidance.
9 January 2026
···
Robinhood stock slips after CEO share sale; jobs report and Feb. 10 earnings set the next test

Robinhood stock slips after CEO share sale; jobs report and Feb. 10 earnings set the next test

Robinhood shares fell 1.4% to $115.39 in after-hours trading after filings showed CEO Vlad Tenev sold 375,000 shares worth $45.6 million under a pre-set plan. The stock moved between $113.90 and $117.30 during the regular session. Investors await Friday’s U.S. jobs report for rate clues and Robinhood’s Feb. 10 earnings release. Crypto markets and peer broker stocks also edged lower.
9 January 2026
··
Applied Digital (APLD) stock jumps after earnings beat as AI data-center lease talks stay in focus

Applied Digital (APLD) stock jumps after earnings beat as AI data-center lease talks stay in focus

Applied Digital shares climbed 8% to $31.94 in after-hours trading Thursday after quarterly revenue beat estimates, reaching $126.6 million. The company highlighted new long-term leases for AI data centers and said its Polaris Forge 1 site delivered 100 megawatts on schedule. Cash and equivalents totaled $1.91 billion as of Nov. 30, with $2.59 billion in long-term debt. Investors await further lease conversions and Friday’s U.S. jobs report.
9 January 2026
····
Microsoft stock slips after Copilot Checkout push; MSFT earnings loom

Microsoft stock slips after Copilot Checkout push; MSFT earnings loom

Microsoft shares fell 1.1% to $478.11 in after-hours trading Thursday, tracking declines in other tech stocks as the Nasdaq slipped 0.44%. The company announced the U.S. launch of Copilot Checkout, a chat-based shopping tool partnering with PayPal, Shopify, and Stripe. Investors remain cautious about AI spending translating into revenue. Microsoft reports fiscal Q2 results on Jan. 28.
9 January 2026
·····
AMD stock falls 2.5% as tech retreats, Feb. 3 earnings and CES AI chips in focus

AMD stock falls 2.5% as tech retreats, Feb. 3 earnings and CES AI chips in focus

AMD shares fell 2.5% to $204.68 after market close Thursday, mirroring declines in chip stocks and broader tech. Investors are watching for AMD’s Feb. 3 earnings report, focused on data-center accelerator shipments after new chip unveilings at CES. CEO Lisa Su highlighted the MI455 and MI440X processors, targeting Nvidia’s market share. CTO Mark Papermaster will speak at a Morgan Stanley conference on March 3.
9 January 2026
···
Nvidia stock slips after report on China H200 payments as jobs data and earnings loom

Nvidia stock slips after report on China H200 payments as jobs data and earnings loom

Nvidia shares fell 2.1% to $185.04 in after-hours trading Thursday after Reuters reported the company is demanding full upfront payment from Chinese buyers for its H200 AI chips. Chinese firms have ordered over 2 million units, far exceeding Nvidia’s inventory. The U.S. jobless rate held at 4.6% in December, with markets pricing slim odds of a Fed rate cut in January. Investors await Friday’s jobs report and any update on China chip approvals.
8 January 2026
···
Goldman Sachs stock slips as Apple Card handoff puts a Q4 earnings bump on the table

Goldman Sachs stock slips as Apple Card handoff puts a Q4 earnings bump on the table

Goldman Sachs shares fell 0.7% after announcing it will transfer the Apple Card program to JPMorgan Chase. Goldman expects a $0.46 per-share boost to Q4 2025 earnings from a $2.48 billion loan-loss reserve release, offset by $2.26 billion in related costs. JPMorgan will take on over $20 billion in Apple Card balances and expects a $2.2 billion credit loss provision. The handover is set to take about two years.
8 January 2026
····
1 … 158 159 160 161 162 … 257

Stock Market Today

  • Palantir Technologies Valuation Insights: PLTR Stock Analysis
    June 18, 2026, 7:43 PM EDT. Palantir Technologies (PLTR) trades at $130.63 with a market cap of $312.7 billion and a trailing price-to-earnings (P/E) ratio of 137.1x, indicating a significant premium. Revenue grew 67.7% last year, with a 3-year compound annual growth rate (CAGR) of 39.6%. Net margins stand at 43.7%, near the company's peak. To justify its valuation, Palantir needs to sustain a 33.7% revenue CAGR over seven years, while margins normalize to about 27.3% and P/E falls to 28.8x. Current high growth rates are cyclical peaks, making the stock's valuation sensitive to performance shifts. Analysts caution investing in PLTR without diversification due to its fragile single-stock risk, recommending portfolio strategies like the Trefis High Quality Portfolio to mitigate volatility and capitalize on broader market opportunities.

Latest articles

Cisco trades higher ahead of Juneteenth holiday with AI-networking names in the mix

Cisco trades higher ahead of Juneteenth holiday with AI-networking names in the mix

19 June 2026
Cisco surged 1.88% to $119.54 on heavy volume, snapping a four-day slide as investors bet on its raised $9 billion AI-infrastructure order target from hyperscale customers, but risks remain if AI demand slows or revenue conversion lags, especially with U.S. markets closed Friday for Juneteenth and after recent restructuring news.
Rocket Lab Drops Even After Nasdaq-100 Nod, SpaceX IPO Buzz Fades

Rocket Lab stock slips as Nasdaq-100 entry nears and SpaceX fever cools

19 June 2026
Rocket Lab fell 0.7% to $107.24 in heavy trading as investors weighed its upcoming Nasdaq-100 inclusion Monday against pressure from SpaceX’s post-IPO drop; despite a 63.5% revenue jump and KeyBanc’s upgrade, Rocket Lab posted a $45 million Q1 loss and faces risks tied to Neutron’s development.
Go toTop